Back

The prognostic significance of atrial fibrillation in patients with ST-elevation myocardial infarction: a sub-study of the randomized TOTAL trial

26 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Best Posters 2 - Best Posters in atrial fibrillation in STEMI - A harmless bystander? ST-Elevation Myocardial Infarction (STEMI) ESC Premium Access ESC Congress 2018

About the speaker

Photo
Mr Eero Mikko Juhani Anttonen

Tampere University, Tampere (Finland)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor S. Reinstadler (Innsbruck, AT)
Abstract Slides
Presentation thumbnail
Assistant Professor T. Podolecki (Zabrze, PL)
Abstract Slides
Presentation thumbnail
Professor P. Sulzgruber (Krems an der Donau, AT)
Abstract Slides

Access the full session

Session thumbnail
Best Posters 2 - Best Posters in atrial fibrillation in STEMI - A harmless bystander?

The Event

Event poster

ESC Congress 2018

26 August 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Early vs late new-onset atrial fibrillation in STEMI patients: pathophysiological mechanisms and relationship with in-hospital outcomes
27 August 2021
thumbnail
Webinar
ACVC Biomarker Talk Series - Biomarkers in atrial fibrillation
24 November 2021
thumbnail
Congress Presentation
Meta-analysis of clinical trials comparing triple versus dual antithrombotic therapy on risk reduction of stent thrombosis after percutaneous coronary intervention in atrial fibrillation patients
27 August 2021
thumbnail
Congress Session
Treatment strategies for atrial fibrillation in heart failure
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources